RUTH L. KATZ, M.D.
Medical Practice in Houston, TX
License number
Texas F6263
Category
Medical Practice
Type
Cytopathology
Address
Address
1515 Holcombe Blvd., Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about RUTH L. KATZ at radaris.comName
Address
Phone
5335 Queensloch Dr, Houston, TX 77096
945 S Mesa Hills Dr APT 3214, El Paso, TX 79912
7627 Pecan Villas Dr APT B, Houston, TX 77061
721 Yorkshire Ct, El Paso, TX 79922
7627 Pecan Villas Dr, Houston, TX 77061
Organization information
See more information about RUTH L. KATZ at bizstanding.comUniversity TX MD Anderson Cancer Center - Ruth L Katz MD
1515 Holcombe Blvd #53, Houston, TX 77030
Categories:
Pathology Physicians & Surgeons
Phone:
(713) 794-5625 (Phone)
Ruth L Katz
1515 Holcombe Blvd, Houston, TX 77030
Status:
Inactive
Industry:
Medical Doctor's Office
Phone:
(713) 794-5625 (Phone)
Medical Doctors:
Matthew Harold Katz Medical Doctor, inactive,Ruth Katz Medical Doctor, inactive
Categories:
Pathology Physicians & Surgeons
Professional information
See more information about RUTH L. KATZ at trustoria.com
Professor Of Pathology At Md Anderson Cancer Center
Professor Of Pathology At Md Anderson Cancer Center
Position:
Professor of pathology at MD Anderson Cancer center
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
MD Anderson Cancer center
since Aug 1978
-
Professor of pathology
Education:
Tufts University School of Medicine 1976 - 1978
Resident, Anatomical pathology University of the Witwatersrand 1964 - 1969
MB BCh, Medicine University of the Witwatersrand 1963 - 1969
M.B.Bch, Mdicine Johannesburg Girls High School 1958 - 1962
Resident, Anatomical pathology University of the Witwatersrand 1964 - 1969
MB BCh, Medicine University of the Witwatersrand 1963 - 1969
M.B.Bch, Mdicine Johannesburg Girls High School 1958 - 1962
Languages:
Afrikaans
Dr. Ruth L Katz, Houston TX - MD (Doctor of Medicine)
Dr. Ruth L Katz, Houston TX - MD (Doctor of Medicine)
Specialties:
Cytopathology
Address:
1515 Holcombe Blvd SUITE 53, Houston 77030
(713) 792-6161 (Phone)
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
(713) 792-6161 (Phone)
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
Certifications:
Anatomic & Clinical Pathology, 1981, Cytopathology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1515 Holcombe Blvd SUITE 53, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
University of The Witwatersrand/Faculty of Health Sciences
Edenvale
Beth Israel Deaconess Medical Center
Univ Of Tex MD Anderson Cancer Center
University of The Witwatersrand/Faculty of Health Sciences
Edenvale
Beth Israel Deaconess Medical Center
Univ Of Tex MD Anderson Cancer Center
Methods And Kits For Diagnosing Lung Cancer
Methods And Kits For Diagnosing Lung Cancer
US Patent:
2010031, Dec 16, 2010
Filed:
Oct 6, 2008
Appl. No.:
12/682594
Inventors:
Michal Daniely - Ganei Tikva, IL
Lea Madi - Rishon-LeZion, IL
Tal Kaplan - Gan-Yavne, IL
Boaz Pal - Tel-Aviv, IL
Yuval Harari - D.N. Emek Soreq, IL
Tanweer M. Zaidi - Houston TX, US
Ricardo L. Fernandez - Houston TX, US
Jinping Zhang - Houston TX, US
Ruth Katz - Houston TX, US
Lea Madi - Rishon-LeZion, IL
Tal Kaplan - Gan-Yavne, IL
Boaz Pal - Tel-Aviv, IL
Yuval Harari - D.N. Emek Soreq, IL
Tanweer M. Zaidi - Houston TX, US
Ricardo L. Fernandez - Houston TX, US
Jinping Zhang - Houston TX, US
Ruth Katz - Houston TX, US
Assignee:
Bioview Ltd. - Nes Ziona
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Provided is a method of identifying a genetically abnormal cell in a sputum sample, the method comprising: (a) staining a sputum sample using a morphological stain so as to identify a lower airway tract cell or lung cell in the sputum sample; and (b) staining the sputum sample using fluorescent in situ hybridization (FISH) so as to identify in the lower airway tract cell or lung cell a genetic abnormality in at least one of human chromosome 3p22.1 and 10q22-23, thereby identifying the genetically abnormal cell in the sputum sample. Also provided are methods and kits of diagnosing lung cancer by detecting a presence of genetically abnormal cells above a predetermined threshold in a sputum sample.
Ruth L Katz, Houston TX
Ruth L Katz, Houston TX
Specialties:
Pathologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
University of the Witwatersrand, Faculty of Health Sciences - Doctor of Medicine
Beth Israel Deaconess Medical Center - Residency - Anatomic Pathology
Beth Israel Deaconess Medical Center - Residency - Anatomic Pathology
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Cytopathology (Pathology)
Detection And Diagnosis Of Smoking Related Cancers
Detection And Diagnosis Of Smoking Related Cancers
US Patent:
6797471, Sep 28, 2004
Filed:
Aug 6, 2001
Appl. No.:
09/923304
Inventors:
Ruth Katz - Houston TX
Feng Jiang - Houston TX
Feng Jiang - Houston TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C07H 2104
US Classification:
435 6, 536 231
Abstract:
Gene probes for specific regions of chromosome 3 (3p21. 3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.
Circulating Tumor And Tumor Stem Cell Detection Using Genomic Specific Probes
Circulating Tumor And Tumor Stem Cell Detection Using Genomic Specific Probes
US Patent:
2011018, Aug 4, 2011
Filed:
Jul 7, 2009
Appl. No.:
13/002944
Inventors:
Ruth L Katz - Houston TX, US
Abha Khanna - Sugar Land TX, US
Tanweer M. Zaidi - Missouri City TX, US
Weigong He - Sugar Land TX, US
Ricardo L. Fernandez - Houston TX, US
Ivan Gorlov - Houston TX, US
Abha Khanna - Sugar Land TX, US
Tanweer M. Zaidi - Missouri City TX, US
Weigong He - Sugar Land TX, US
Ricardo L. Fernandez - Houston TX, US
Ivan Gorlov - Houston TX, US
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
The present invention comprises a method of detecting circular tumor cells and methods of detecting, evaluating, or staging cancer in a patient, as well as a method of monitoring treatment of cancer in a patient using the claimed method. The method comprises contacting a sample with a CD45 binding agent; selecting the cells based on positive or negative CD45 staining; contacting the selected cells with a labeled nucleic acid probe, and detecting hybridized cells by fluorescence in situ hybridization; and analyzing a signal produced by the labels on the hybridized cells to detect the CTCs. In other embodiments, the method provides for directed to a method of determining the level of CTCs in a sample having blood cells from a patient by contacting a sample having blood cells from a patient, wherein the sample has not been pre-sorted into CD45-positive and CD45-negative cells.
Detection And Diagnosis Of Smoking Related Cancers
Detection And Diagnosis Of Smoking Related Cancers
US Patent:
7741034, Jun 22, 2010
Filed:
Sep 28, 2004
Appl. No.:
10/952251
Inventors:
Ruth Katz - Houston TX, US
Feng Jiang - Houston TX, US
Feng Jiang - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C07H 21/04, C12Q 1/68
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
Gene probes for specific regions of chromosome 3 (3p21. 3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.
Detection And Diagnosis Of Smoking Related Cancers
Detection And Diagnosis Of Smoking Related Cancers
US Patent:
8093001, Jan 10, 2012
Filed:
Apr 15, 2010
Appl. No.:
12/761134
Inventors:
Ruth Katz - Houston TX, US
Feng Jiang - Houston TX, US
Feng Jiang - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C07H 21/04, C12Q 1/68
US Classification:
435 61, 435 611, 435 614, 435 911, 435 912, 536 231, 536 243
Abstract:
Gene probes for specific regions of chromosome 3 (3p21. 3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.
Detection And Diagnosis Of Smoking Related Cancers
Detection And Diagnosis Of Smoking Related Cancers
US Patent:
2007021, Sep 20, 2007
Filed:
Jan 25, 2007
Appl. No.:
11/627253
Inventors:
Ruth Katz - Houston TX, US
Feng Jiang - Ellicott City MD, US
Feng Jiang - Ellicott City MD, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Gene probes for specific regions of chromosomes 1, 3, 9, 10 and 17 are now shown to be useful in the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, to determine susceptibility to the development of smoking related cancers, to predict cancer progression and treatment efficacy, and to rule out other diseases.
Diagnosis And Prognosis Of Cancer Based On Telomere Length As Measured On Cytological Specimens
Diagnosis And Prognosis Of Cancer Based On Telomere Length As Measured On Cytological Specimens
US Patent:
2009016, Jun 25, 2009
Filed:
Aug 31, 2005
Appl. No.:
11/574449
Inventors:
Ruth L. Katz - Houston TX, US
Jun Gu - Houston TX, US
Abha Khanna - Houston TX, US
Ricardo Fernandez - Houston TX, US
Jun Gu - Houston TX, US
Abha Khanna - Houston TX, US
Ricardo Fernandez - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention concerns a quantitative in situ assessment of mean telomere length, particularly in relation to nuclear area, for the diagnosis and/or prognosis of cancer. In particular aspects, the methods and compositions regard diagnosis and/or prognosis of bladder cancer, urothelial cancer, lung cancer, and lymphoma.